Innogenetics
Europe, Oost-Vlaanderen, Belgium, Gent
Description
Innogenetics is a specialty diagnostics company developing therapies and diagnostic products for infectious diseases.
Investor Profile
Innogenetics has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Biotechnology, Health Care, Manufacturing.
Stage Focus
- Series Unknown (50%)
- Series C (50%)
Country Focus
- United Kingdom (50%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- United States (50%)
Industry Focus
- Biotechnology
- Health Care
- Manufacturing
- Genetics
- Health Diagnostics
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Innogenetics frequently co-invest with?
What are some of recent deals done by Innogenetics?
Find More Investors Like Innogenetics
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
